Curaleaf Holdings announced today it closed the acquisition of Select as of the 1st of February, 2020.
Curaleaf Holdings, Inc. (CSE: CURA), a leading vertically integrated cannabis operator in the United States, today announced that it closed the transformational acquisition of Select on February 1. With the completion of the acquisition, Curaleaf solidifies its stance as the largest cannabis operator in the U.S. in terms of operational and wholesale footprint, including 53 open dispensaries, and positions the Company well for its next phase of growth.
Curaleaf's acquisition of Cura Partners, Inc. ("Cura"), owners of the Select brand, includes Select's manufacturing, distribution, marketing and sales operations marketed under the Select brand name, including all intellectual property.
The close of the Select deal is a major milestone in Curaleaf's history and marks an unprecedented phase of growth for our company. Joseph Lusardi, CEO of Curaleaf.
Lusardi went on to say that "as we've scaled, Curaleaf has pioneered the U.S. cannabis industry, and we're incredibly excited about the future and our leadership role in it. Our entire organization is focused on accelerating our growth as a combined company with two of the fastest growing cannabis brands in the country."
The closing provides tremendous opportunities for synergies as it combines Curaleaf's national retail locations, vertically integrated structure, wellness brand, product range and East Coast hub with Select's wholesale model, established lifestyle brand and leading West Coast market presence.
The news comes on the heels of Curaleaf's acquisition of the Acres Cannabis vertical operations in Nevada, and the awarding of preliminary retail and processing licenses in Utah.
Curaleaf Expands Leadership Team to Drive the Company Forward
With the closing, visionary entrepreneur Cameron Forni assumes the role of President of Select and will focus on driving growth of the Select brand through expansion into new markets. Mr. Forni, who founded Select in 2015, is recognized as a leading authority on vaporizer cartridges and has played an instrumental role in building Select's award-winning brand, culture and operations across California, Oregon, Arizona and Nevada.
Renowned brand marketer Jason White joins Curaleaf from Select in the newly created role of Chief Marketing Officer, where he will drive the Company's overall marketing and brand strategy. Mr. White brings 20 years of experience as an award-winning advertising and marketing professional and has built a highly acclaimed career creating culture-shaping ideas for Fortune 100 companies. Prior to Select, Mr. White was the Global Head of Marketing for Beats by Dr. Dre which was acquired by Apple in 2014. Prior to Beats, he was Managing Director at Wieden + Kennedy Shanghai for lead client Nike as they prepared for the 2008 Beijing Olympics. Mr. White also served as Global Account Director on Nike at Wieden + Kennedy in Portland, Oregon, developing campaigns for LeBron James, Kobe Bryant and Tiger Woods.
Curaleaf Chief Financial Officer Neil Davidson has been elevated to Chief Operating Officer effective immediately. Mr. Davidson will be responsible for managing the Company's cultivation, processing and manufacturing capabilities with a focus on driving growth and operational efficiencies across the entire organization. Former Chief Operating Officer Stuart Wilcox will transition to a new role, leading business expansion efforts in emerging markets.
In addition, Michael Carlotti joined Curaleaf today as Chief Financial Officer, succeeding Mr. Davidson. Mr. Carlotti will be responsible for leading the Company's finance, capital markets, M&A, treasury and investor relations functions. Prior to joining Curaleaf, Mr. Carlotti was the Chief Financial Officer for a Nevada-based cannabis company. Mr. Carlotti spent nearly a decade in the gaming industry including having served as Senior Vice President and Treasurer at MGM Resorts International, an S&P 500 global entertainment company. He began his career in investment banking with positions at Smith Barney and Wachovia Securities.
Mark Russ has been appointed Senior Vice President of Sales and will oversee national sales of all Curaleaf brands. Mr. Russ joins Curaleaf from a vertically integrated cannabis company, where he served as Vice President of Sales. Prior to that he served as Vice President & General Sales Manager at Constellation Brands, where he was responsible for overseeing the operations of multiple states. Mr. Russ also spent nearly 10 years with the West Business Unit at Red Bull North America as Vice President and General Manager and was responsible for all sales, marketing, distribution and operations for 10 western states.
"Curaleaf has always been a fast-paced, performance-driven company, and we continue to attract best-in-class talent to fill key management roles. We're thrilled to be expanding our leadership bench to include individuals with unmatched expertise combined with a deep passion for this business," said Lusardi.
Curaleaf Announces New Board Member
Dr. Jaswinder Grover, MD, an orthopedic and spine surgeon with 25 years of experience, joins the Curaleaf Board of Directors, replacing Dr. Steven Patierno, PhD. Dr. Patierno will remain in his role as the Chairman of the Company's Medical Advisory Board. Dr. Grover is renowned in the medical community and is the founder and developer of the Allegiant Institute, a comprehensive referral center and clinic for the treatment of patients suffering from pain, spine, and musculoskeletal disorders and the Smoke Ranch Surgery Center and Center for Special Surgery, Joint Commission accredited centers for surgical and interventional care.
"We are pleased to welcome Dr. Jaswinder Grover to the Curaleaf Board of Directors. His experience and leadership will provide an invaluable new perspective to our Board and management team," said Boris Jordan, Executive Chairman of Curaleaf. "I'd like to thank Dr. Steven Patierno for his expertise and dedication to the Company over the past several years, helping Curaleaf grow from a small medical device company to one of the leading cannabis companies in the world."
To learn more about Curaleaf, visit their company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
This could be one of the best investing opportunities of 2020
Legislative changes are blowing through the US, and with it, an ever-increasing number of states legalising cannabis for recreational use.
With the success seen in Illinois, which legalised for adult-use on January 1 and saw products moving off the shelf at an unprecedented rate, this company is primed to take advantage of the booming US recreational market.
They have secured partnerships with the biggest cannabis companies in the US, and their portfolio is second to none.
And with the sector-wide pullback of 2019, this company is now at a bargain-basement price.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors